Published in Am J Ophthalmol on July 01, 1968
The cornea--structure and macromolecules in health and disease. A review. Am J Pathol (1977) 1.19
Laser photocoagulation for corneal stromal vascularization. Trans Am Ophthalmol Soc (1992) 0.81
The Viviparous-1 developmental gene of maize encodes a novel transcriptional activator. Cell (1991) 6.84
THE BLOOD FLOW, VASCULAR RESISTANCE, AND OXYGEN CONSUMPTION OF THE BRAIN IN ESSENTIAL HYPERTENSION. J Clin Invest (1948) 3.95
Analysis of partial volume effects in diffusion-tensor MRI. Magn Reson Med (2001) 3.66
C-terminal domains of human translation termination factors eRF1 and eRF3 mediate their in vivo interaction. FEBS Lett (1999) 1.77
Obtaining consent for eye donation. Isr J Med Sci (1991) 1.64
Interpretation of tear film breakup. Arch Ophthalmol (1977) 1.56
Brittle cornea. A familial trait associated with blue sclera. Am J Ophthalmol (1968) 1.53
Reproducibility of topographic measures of the glaucomatous optic nerve head. Br J Ophthalmol (1998) 1.46
Tono-Pen tonometry in normal and in post-keratoplasty eyes. Br J Ophthalmol (1992) 1.42
Giant cavernous hemangioma of the face. Arch Ophthalmol (1994) 1.39
Isolation of murine neuron-specific and non-neuronal enolase cDNA clones. Biochem Biophys Res Commun (1986) 1.36
Congenital fibrosis of the extraocular muscles (autosomal dominant congenital external ophthalmoplegia): genetic homogeneity, linkage refinement, and physical mapping on chromosome 12. Am J Hum Genet (1995) 1.30
Chloramphenicol optic neuropathy. Arch Ophthalmol (1980) 1.29
Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol (1977) 1.29
[Studies of the method of culture of N. gonorrhoeae in tissue cultures]. Actas Dermosifiliogr (1970) 1.15
Visual fields in diabetic retinopathy. Br J Ophthalmol (1971) 1.15
Collapse of the N=28 shell closure in (42)Si. Phys Rev Lett (2007) 1.13
[Pathogenesis and therapy of tetanus]. Schweiz Med Wochenschr (1970) 1.13
Acute glaucoma, ectopia lentis and homocystinuria. Am J Ophthalmol (1966) 1.09
Clinical experience with nucleosides in herpes simplex eye infections in man and animals. Ann N Y Acad Sci (1965) 1.09
"The disappearing lens": failure of CT to image the lens in traumatic intumescent cataract. J Comput Assist Tomogr (1999) 1.08
Diacetyl nadolol: 3-month ocular hypotensive effect in glaucomatous eyes. Br J Ophthalmol (1983) 1.06
Histocompatibility (HL-A) antigens and primary open-angle glaucoma. Tissue Antigens (1976) 1.05
Intraocular penetration of cephaloridine in humans. Am J Ophthalmol (1968) 1.05
The incidence of uveitis in multiple sclerosis. Am J Ophthalmol (1966) 1.04
Serratia marcescens, an ocular pathogen; new considerations. Arch Ophthalmol (1971) 1.04
Serotypes of Ureaplasma urealyticum isolated from patients with nongonococcal urethritis and gonorrhea and from asymptomatic urethral carriers. Sex Transm Dis (1986) 1.03
Marginal (ring) corneal ulcer as presenting manifestation of Wegener's granuloma. A clinicopathologic study. Trans Am Acad Ophthalmol Otolaryngol (1971) 1.01
The role of lymphocyte (cell-mediated) immunity in ocular disease. The fifth Frederick H. Verhoeff lecture. Am J Ophthalmol (1973) 1.01
Drug-induced retinal toxicity in albino rabbits: the effects of imipenem and aztreonam. Invest Ophthalmol Vis Sci (1993) 1.00
Ocular pigmentation and pressure and outflow responses to pilocarpine and epinephrine. Am J Ophthalmol (1971) 1.00
Heavy isotope-labeling study of the metabolism of monomeric and tetrameric acetylcholinesterase forms in the murine neuronal-like T 28 hybrid cell line. J Biol Chem (1984) 0.99
Late onset corneal haze after photorefractive keratectomy for moderate and high myopia. Ophthalmology (1997) 0.99
Mycobacterium fortuitum keratitis. Am J Ophthalmol (1974) 0.99
Episcleral traumatic conjunctival inclusion cyst. Br J Ophthalmol (1977) 0.99
Intentional retention of Descemet's membrane in keratoplasty for the surgical treatment of bullous keratopathy. Acta Ophthalmol (Copenh) (1993) 0.97
A clinical evaluation of the effects of topically applied levobunolol and timolol on increased intraocular pressure. Am J Ophthalmol (1982) 0.96
Hypotony as a late complication of extracapsular cataract extraction. Am J Ophthalmol (1983) 0.96
The potential use of quinolones in future ocular antimicrobial therapy. Am J Ophthalmol (1988) 0.95
Intraorbital glomus cell tumor. Am J Ophthalmol (1994) 0.94
The p.P56S mutation in the VAPB gene is not due to a single founder: the first European case. Clin Genet (2010) 0.93
Biochemical characterization of the mouse muscle-specific enolase: developmental changes in electrophoretic variants and selective binding to other proteins. Biochem J (1997) 0.93
Inhibition of leucocyte migration by corneal antigen in chronic viral keratitis. Nat New Biol (1971) 0.92
Oral isosorbide and intraocular pressure. Am J Ophthalmol (1970) 0.92
[On the properties of a modified alanyl-t-RNA synthetase in a strain of escherichia coli with thermosensible growth]. C R Acad Sci Hebd Seances Acad Sci D (1968) 0.92
Diffusional kurtosis imaging of the developing brain. AJNR Am J Neuroradiol (2013) 0.92
Successful management of bleeding complications in patients supported with extracorporeal membrane oxygenation with primary respiratory failure. Perfusion (2012) 0.92
Bilateral amyloidosis of the vitreous body: report of a case without systemic of familial involvement. Arch Ophthalmol (1976) 0.91
Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. Ophthalmology (1999) 0.91
Clinical evaluation of the Humphrey automatic refractor. Arch Ophthalmol (1984) 0.91
Sector retinitis pigmentosa in juvenile nephronophthisis. Br J Ophthalmol (1980) 0.90
Macular ring in a patient with Terson's syndrome. Acta Ophthalmol Scand (1999) 0.90
Intraocular penetration of cephalexin in man. Am J Ophthalmol (1970) 0.90
Use of flurbiprofen to inhibit corneal neovascularization. Arch Ophthalmol (1980) 0.90
Laser in situ keratomileusis to correct hyperopic shift after radial keratotomy. J Cataract Refract Surg (2001) 0.90
Topical hetrazan in the treatment of ocular onchocerciasis. Am J Ophthalmol (1970) 0.90
Cellular immunity in chronic ophthalmic disorders. 3. Leukocyte migration inhibition in uveitis. Am J Ophthalmol (1972) 0.89
Hypotensive effect of bromocriptine in glaucomatous eyes. J Ocul Pharmacol (1987) 0.89
Effect of sub-Tenon's and peribulbar anesthesia on intraocular pressure and ocular pulse amplitude. J Cataract Refract Surg (2001) 0.89
Bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate reductase mutation. Am J Ophthalmol (1997) 0.89
The additive miotic effects of dapiprazole and pilocarpine. Graefes Arch Clin Exp Ophthalmol (1995) 0.88
Clinical immunology in ophthalmology. The 1975 Bedell lecture. Am J Ophthalmol (1976) 0.88
New dimensions in ocular pharmacology. XXII Edward Jackson Memorial Lecture. Am J Ophthalmol (1966) 0.88
Prevalence of nevocytic nevi on lateral and medial aspects of arms. J Dermatol Surg Oncol (1978) 0.88
Cavernous haemangioma of the orbit: treatment by transconjunctival cryoextraction. Eye (Lond) (1993) 0.87
Armillifer armillatus in a human eye. Am J Ophthalmol (1967) 0.87
Zinc deficiency and visual impairment? Am J Ophthalmol (1978) 0.87
Differential expression of alpha- and beta-enolase genes during rat heart development and hypertrophy. Am J Physiol (1995) 0.87
Modulation of the distribution of acetylcholinesterase molecular forms in a murine neuroblastoma x sympathetic ganglion cell hybrid cell line. J Neurochem (1980) 0.87
Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett (1995) 0.87
The use of aceclydine in the treatment of glaucoma. Its effect on intraocular pressure and facility of aqueous humor outflow as compared to that of pilocarpine. Am J Ophthalmol (1967) 0.87
Macular hemorrhage after excimer laser photorefractive keratectomy. J Cataract Refract Surg (1997) 0.86
Mycobacterium fortuitum infection of corneal graft. Arch Ophthalmol (1969) 0.86
Effectiveness of sub-Tenon's versus peribulbar anesthesia in extracapsular cataract surgery. J Cataract Refract Surg (1999) 0.86
Anterior pupillary block. Acta Ophthalmol (Copenh) (1981) 0.86
Treatment of uveitis with methotrexate. Am J Ophthalmol (1969) 0.86
Artificial embolic occlusion of the terminal internal carotid artery in the treatment of carotid-cavernous fistula. Technical note. J Neurosurg (1968) 0.86
Cilioretinal artery occlusion during coronary catheterization. Acta Ophthalmol Scand (1999) 0.86
Activation of the gene encoding the glycolytic enzyme beta-enolase during early myogenesis precedes an increased expression during fetal muscle development. Mech Dev (1992) 0.85
Murine muscle-specific enolase: cDNA cloning, sequence, and developmental expression. Proc Natl Acad Sci U S A (1989) 0.85
Topical diethylcarbamazine in the treatment of ocular onchocerciasis. Am J Trop Med Hyg (1970) 0.85
Consequences of amino-terminal deletions of preproparathyroid hormone signal sequence. Mol Endocrinol (1987) 0.85
Combined phacoemulsification and scleral buckling operation. Am J Ophthalmol (1977) 0.85
Fusarium solani endophthalmitis without primary corneal involvement. Am J Ophthalmol (1979) 0.85
Sudden blindness after thermocoagulation of the trigeminal ganglion. Ann Ophthalmol (1990) 0.84
Retinal manifestations in familial juvenile nephronophthisis. Clin Genet (1979) 0.84
Complications of excimer laser photorefractive keratectomy for myopia. J Cataract Refract Surg (1997) 0.84
Cellular immunity in chronic ophthalmic disorders. 2. Leukocyte migration inhibition in diseases of the cornea. Am J Ophthalmol (1972) 0.84
Resistance of the rabbit to streptozotocin. Lancet (1968) 0.84
Leucocyte-migration inhibition induced by uveoretinal antigen in patients with diabetic retinopathy. Diabetes (1976) 0.83
Intraocular penetration of sodium cephalothin in man after subconjunctival injection. Am J Ophthalmol (1972) 0.83